Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,328,506 papers from all fields of science
Search
Sign In
Create Free Account
OK-432
Known as:
Streptococcal OK 432
, Streptococcal OK432
, 432 ok
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Picibanil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Adult cystic hygroma: successful use of OK-432 (Picibanil®)
S. Woolley
,
D. Smith
,
S. Quine
Journal of Laryngology and Otology
2008
Corpus ID: 11612789
Abstract Objective: We report an adult case of cystic lymphangioma treated with OK-432 (Picibanil®). Method: A case report and…
Expand
2006
2006
Antitumor Effect of OK-432–Derived DNA: One of the Active Constituents of OK-432, a Streptococcal Immunotherapeutic Agent
T. Oshikawa
,
M. Okamoto
,
+7 authors
Mitsunobu Sato
Journal of immunotherapy
2006
Corpus ID: 38148173
OK-432 is a Streptococcus-derived immunotherapeutic agent for malignancies. Our group has tried to identify the effective…
Expand
1997
1997
Local injection of OK432 can augment the TH1‐type T‐cell response in tumor‐draining lymph node cells and increase their immunotherapeutical potential
T. Okamoto
,
M. Harada
,
+7 authors
K. Nomoto
International Journal of Cancer
1997
Corpus ID: 46579314
The effect of local injections with streptococcal preparation OK432 on the therapeutical potential of tumor‐draining lymph node…
Expand
1994
1994
Cystic lymphangioma and plunging ranula treated by OK-432 therapy: a report of two cases.
T. Ikarashi
,
K. Inamura
,
Y. Kimura
Acta oto-laryngologica. Supplementum
1994
Corpus ID: 39599114
Among head and neck angiotumors, cystic lymphangioma occurs in infancy in most cases and it is rare in adulthood. Plunging ranula…
Expand
1991
1991
Post-irradiation treatment with OK432 can prevent radiation-induced bone marrow death.
A. Kurishita
,
H. Katoh
,
+5 authors
S. Okada
International Journal of Radiation Biology
1991
Corpus ID: 46356040
The radioprotective effect of OK432, a Streptococcus haemolyticus preparation, on bone marrow death was examined in mice. The…
Expand
1987
1987
Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.
Y. Watanabe
,
T. Iwa
Journal of Biological Response Modifiers
1987
Corpus ID: 41281957
A streptococcal preparation, OK-432, was employed as the adjuvant immunotherapeutic agent combined with chemotherapy in cases of…
Expand
1986
1986
Interferon‐γ Induction in Human Peripheral Blood Mononuclear Cells by OK‐432, a Killed Preparation of Streptococcus pyogenes
T. Noda
,
M. Asano
,
O. Yoshie
,
T. Ebina
,
N. Ishida
,
R. Suzuki
Microbiology and immunology
1986
Corpus ID: 45850708
produced IL-2 when the cells were obtained from mice presensitized with OK-432. They also described a lymphokine, distinct from…
Expand
1981
1981
Effect of a streptococcal preparation, OK-432, on hematopoietic spleen colony formation in irradiated mice.
A. Hiraoka
,
M. Yamagishi
,
T. Ohkubo
,
T. Kamamoto
,
Y. Yoshida
,
H. Uchino
Cancer Research
1981
Corpus ID: 11061143
In vivo effect of an immunostimulant, OK-432, on hematopoietic spleen colonies (CFU-S) was investigated in irradiated JCL/ICR…
Expand
1979
1979
Protective Effect of OK‐432 (a Streptococcal Preparation) on Experimental Candidiasis
A. Shiraishi
,
Y. Mikami
,
T. Arai
Microbiology and immunology
1979
Corpus ID: 41980384
Candida albicans is known to be one of the major causative agents of opportunistic infection. It is well known that patients with…
Expand
1976
1976
Streptococcus pyogenes preparation OK-432: immunoprophylactic and immunotherapeutic effects on the incidence of spontaneous leukemia in AKR mice.
T. Aoki
,
J. Kvedar
,
V. Hollis
,
G. Bushar
Journal of the National Cancer Institute
1976
Corpus ID: 7834467
An inactivated and lyophilized preparation of a low virulence strain (Su) of Streptococcus pyogenes (group A) was designated OK…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE